Article Details

Providence Therapeutics Announces Very Favorable Interim Phase 1 Trial Data for PTX-COVID19 ...

Retrieved on: 2021-05-12 10:07:30

Tags for this article:

Click the tags to see associated articles and topics

Providence Therapeutics Announces Very Favorable Interim Phase 1 Trial Data for PTX-COVID19 .... View article details on hiswai:

Excerpt

... management of Providence as they compare very favorably to the adverse events data published on other mRNA vaccines for COVID-19 that have ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up